India’s healthcare and pharmaceutical industry is entering a new phase of capability-driven expansion, with projections indicating the creation of 2 to 2.5 million jobs by 2030. However, this growth comes with a structural shift, as nearly 30 to 35 per cent of the workforce will require reskilling to meet evolving industry demands. The transformation is being driven by technological integration, rising specialization, and expansion across segments such as telemedicine, diagnostics, and life sciences.